Quick Answer
Magnesium Taurate Sleep Quality Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Conclusion Magnesium bisglycinate supplementation modestly improved insomnia severity in adults reporting poor sleep quality.
Key Takeaways
- 01Conclusion Magnesium bisglycinate supplementation modestly improved insomnia severity in adults reporting poor sleep quality. [Schuster J (2025)]
- 02Purpose To assess the effects of magnesium bisglycinate supplementation on insomnia symptoms in healthy adults reporting poor sleep quality. [Schuster J (2025)]
- 03Patients and methods This randomized, double-blind, placebo-controlled trial enrolled 155 adults aged 18-65 years with self-reported poor sleep quality. [Schuster J (2025)]
The current Migaku evidence database contains 1 reusable source document for Magnesium Taurate Sleep Quality Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Conclusion Magnesium bisglycinate supplementation modestly improved insomnia severity in adults reporting poor sleep quality. [Schuster J (2025); evidence level 2]
- Purpose To assess the effects of magnesium bisglycinate supplementation on insomnia symptoms in healthy adults reporting poor sleep quality. [Schuster J (2025); evidence level 2]
- Patients and methods This randomized, double-blind, placebo-controlled trial enrolled 155 adults aged 18-65 years with self-reported poor sleep quality. [Schuster J (2025); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources